2-methyl-N-(3,4,5-trimethoxyphenyl)pyrimidin-4-amine

ID: ALA4878867

PubChem CID: 164626903

Max Phase: Preclinical

Molecular Formula: C14H17N3O3

Molecular Weight: 275.31

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1cc(Nc2ccnc(C)n2)cc(OC)c1OC

Standard InChI:  InChI=1S/C14H17N3O3/c1-9-15-6-5-13(16-9)17-10-7-11(18-2)14(20-4)12(8-10)19-3/h5-8H,1-4H3,(H,15,16,17)

Standard InChI Key:  PDJOOWDEWPFMSZ-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 20 21  0  0  0  0  0  0  0  0999 V2000
   10.0915  -30.2531    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.0897  -28.6000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8051  -29.0092    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.8059  -29.8360    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3767  -29.8402    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3790  -29.0146    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0862  -27.7750    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.7988  -27.3595    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5146  -27.7704    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2268  -27.3555    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2237  -26.5296    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5025  -26.1203    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7932  -26.5376    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9359  -26.1131    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.6527  -26.5216    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4960  -25.2954    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.2073  -24.8772    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9429  -27.7653    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.6557  -27.3501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5215  -30.2464    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  5  1  1  0
  1  4  2  0
  3  2  2  0
  2  6  1  0
  3  4  1  0
  5  6  2  0
  2  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
 11 14  1  0
 14 15  1  0
 12 16  1  0
 16 17  1  0
 10 18  1  0
 18 19  1  0
  4 20  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4878867

    ---

Associated Targets(Human)

HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HeLa (62764 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

B16-F10 (4610 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 275.31Molecular Weight (Monoisotopic): 275.1270AlogP: 2.55#Rotatable Bonds: 5
Polar Surface Area: 65.50Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 5.59CX LogP: 1.89CX LogD: 1.89
Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.90Np Likeness Score: -0.91

References

1. Ren Y, Ruan Y, Cheng B, Li L, Liu J, Fang Y, Chen J..  (2021)  Design, synthesis and biological evaluation of novel acridine and quinoline derivatives as tubulin polymerization inhibitors with anticancer activities.,  46  [PMID:34455231] [10.1016/j.bmc.2021.116376]

Source